All Stories

  1. Clinical and Structural Factors Affecting Ablation Outcomes in Atrial Fibrillation Patients - A Review
  2. The 2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia
  3. Arrhythmogenic right ventricular cardiomyopathy: evidence for progression increases
  4. Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study
  5. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy: is this too good to be true?
  6. The role of catheter ablation in the management of ventricular tachycardia
  7. Present understanding of the relationship between exercise and arrhythmogenic right ventricular dysplasia/cardiomyopathy
  8. Sounding the warning on the potential for oesophageal injury resulting from use of the nMARQ  for ablation of atrial fibrillation
  9. Has the Time Come to Recommend Catheter Ablation of Atrial Fibrillation as First-Line Therapy?
  10. Ventricular Tachycardias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
  11. Syncope in Children and Adolescents
  12. Update on atrial fibrillation catheter ablation technologies and techniques
  13. Update on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C)
  14. Arrhythmogenic Right Ventricular Dysplasia
  15. Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
  16. Role of Magnetic Resonance Imaging in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
  17. Reproducibility of automated electrocardiographic measurements
  18. Atrial Fibrillation Ablation in Obese Patients
  19. An Approach to Catheter Ablation of Atrial Fibrillation in the Elderly
  20. Electrophysiological Evaluation of Syncope
  21. Principles of Electrophysiology
  22. Hypotension and Syncope
  23. Reply
  24. Successful cryothermal ablation for Atrioventricular nodal reentry tachycardia after radiofrequency ablation failure
  25. Fusion of imaging technologies: how, when, and for whom?
  26. The Reply
  27. Update on the Management of Atrial Fibrillation: Anticoagulation and Medical Therapy
  28. Magnetic Resonance and Computed Tomographic Imaging in Arrhythmogenic Cardiomyopathy
  29. Use of Mouse Models to Evaluate Novel Therapeutic Approaches to Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy
  30. Complications Associated with Radiofrequency Catheter Ablation of Cardiac Arrhythmias
  31. The role of obesity and sleep apnea in atrial fibrillation
  32. Rhythm Control for Management of Patients With Atrial Fibrillation: Balancing the Use of Antiarrhythmic Drugs and Catheter Ablation
  33. Evaluation of Cardiac Arrhythmia Among Athletes
  34. Arrhythmogenic Right Ventricular Dysplasia
  35. Catheter Ablation of Atrial Flutter and Atrial Fibrillation
  36. State-of-the-art and emerging technologies for atrial fibrillation ablation
  37. Atria and Pulmonary Veins
  38. Role of cardiac imaging evaluation of patients with documented or suspected ventricular arrhythmias
  39. Managed ventricular pacing below the lower rate limit: Is it simply caused by ventricular-based pacing?
  40. Catheter Ablation for AF: Past, Present, and Future
  41. Prevention of progression of atrial fibrillation: A new indication for catheter ablation?
  42. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: An update
  43. Progress Continues in Our Understanding of the Electrocardiographic Manifestations of Arrhythmogenic Right Ventricular Dysplasia
  44. Arrhythmogenic Right Ventricular Dysplasia
  45. To the Editor:
  46. Unusual Presentation of Cardiac Sarcoidosis
  47. To The Editor—Response
  48. Prevention of esophageal injury during catheter ablation of atrial fibrillation: Is intracardiac echocardiography the answer?
  49. Cardiac contractility modulation: A new technologically advanced placebo?
  50. AB22-6
  51. P3-41
  52. Atrial Arrhythmia
  53. Arrhythmogenic right-ventricular dysplasia/cardiomyopathy
  54. Complications Associated with Radiofrequency Catheter Ablation of Cardiac Arrhythmias
  55. Arrhythmogenic right ventricular dysplasia/ cardiomyopathy
  56. Catheter Ablation Therapy for Atrial Fibrillation
  57. Reply
  58. Three Dimensional Mapping of Atrial Fibrillation: Techniques and Necessity
  59. The Evaluation of Syncope: Pearls From the Front Lines
  60. Arrhythmogenic right ventricular dysplasia: A United States experience
  61. Risk stratification in postmyocardial infarction patients: Is there reason to hope?
  62. Arrhythmia Management in the Elderly
  63. Cooled Ablation
  64. Catheter Ablation of Atrial Flutter:
  65. Arrhythmogenic right ventricle dysplasia/cardiomyopathy
  66. Syncope
  67. Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia
  68. MRI of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
  69. Cerebral and Systemic Hemodynamics Changes During Upright Tilt in Chronic Fatigue Syndrome
  70. Magnetic Resonance Imaging of Arrhythmogenic Right Ventricular Dysplasia
  71. Radiofrequency ablation for atrial fibrillation
  72. Radiofrequency catheter ablation of ventricular tachycardia
  73. Complications Associated with Radiofrequency Catheter Ablation of Cardiac Arrhythmias
  74. Catheter Ablation for Cardiac Arrhythmias
  75. Cooled Radiofrequency Catheter Ablation
  76. Premature Ventricular Depolarizations during Exercise
  77. New Approaches to Treating Cardiac Arrythmias using Diffused Laser Radiation
  78. Pharmacologic approaches to therapy for vasovagal syncope11This article may contain discussion of off-label or investigational uses (not yet approved by the FDA) of various therapeutic agents. Please refer to the box provided on page 2Q of this supplem...
  79. Management of Vasovagal Syncope
  80. Neurally mediated hypotension and chronic fatigue syndrome11Based on a talk (by PCR) given at the American Association for Chronic Fatigue Syndrome, October 1996
  81. RELATIONSHIP BETWEEN CHRONIC FATIGUE SYNDROME AND NEURALLY MEDIATED HYPOTENSION
  82. Relationship Between Chronic Fatigue Syndrome and Neurally Mediated Hypotension
  83. Chronic Fatigue Syndrome and Neurally Mediated Hypotension-Reply
  84. Is neurally mediated hypotension an unrecognised cause of chronic fatigue?
  85. Management of Nonsustained Ventricular Tachycardia Guided By Electrophysiological Testing
  86. Diagnostic evaluation and management of syncope
  87. The forestry phase of farm and ranch planning : a handbook for foresters, farm and ranch planners /
  88. Role of Mapping in Arrhythmogenic Right Ventricular Cardiomyopathy
  89. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
  90. Ventricular Arrhythmias in Right Ventricular Dysplasia/Cardiomyopathy
  91. Catheter Ablation of Supraventricular Tachycardias
  92. Alternative Energy Sources for Catheter Ablation
  93. MR and CT Imaging
  94. Syncope and Transient Loss of Consciousness in Children and Adolescents: Congenital and Acquired Conditions